Gastroenterology & Hepatology
A section of Medicina (ISSN 1648-9144).
Section Information
“Hepatology” is an old specialty that involves caring for patients suffering from acute and chronic liver diseases, among the main causes of mortality, including viral, autoimmune, metabolic, and genetic illnesses. Due to the skyrocketing availability of new diagnostic tools and therapeutical approaches, these illnesses require increased attention. Therefore, physicians dealing with hepato-patients require a broad field of knowledge of diagnostic procedures including liver biopsy, ultrasound, TAC, RMN, elastography, EGDS as well as an understanding of surgical methods for shunting and/or liver transplantation, of invasive approaches for hepatocarcinoma, and finally of antiviral therapy. Last but not least, hepatologists should have a multidisciplinary and interprofessional environment to support top-quality care.
The section “Hepatology” of the journal Medicina is devoted to the propagation of novel findings and state-of-the-art knowledge in the field of liver disease of every etiology.
The main aim is advancing the growth of diagnosis and therapy of non-alcoholic fatty liver disease (NAFLD), which, due to the obesity pandemic, has surged to unprecedented levels and is one of the most frequent motivations for liver transplantation and causes of hepatocarcinoma, deepening its spectrum, i.e., simple fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis post-NASH.
Topics of interest for this section include, but are not limited, to the following:
- Basic and clinical research in NAFLD diagnosis and therapy;
- Therapy and follow-up of patients suffering from viral infections (HBV, HBV, HDV);
- Early diagnosis of hepatocarcinoma; strategies to cure hepatocarcinoma;
- Liver cirrhosis with its complications (portal hypertension, ascites, hemorrhage, hepato-renal syndrome, hepatic encephalopathy).
Keywords
- NAFLD
- hepatocarcinoma
- HBV
- HCV
- HDV
- liver transplantation
- hemochromatosis
- primitive biliary cirrhosis
- Wilson’s disease
- alpha1 antitrypsin deficit
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Diagnosis and Treatment of Inflammatory Bowel Disease (Deadline: 30 April 2024)
- Gastrointestinal Bleeding: Management and Complications (Deadline: 30 April 2024)
- Gastroesophageal Reflux Disease and Esophageal Motility Disorders (Deadline: 30 April 2024)
- Pancreatitis—Advances in Diagnosis and Management of Acute, Chronic, Autoimmune and Postoperative Pancreatitis (Deadline: 10 May 2024)
- Novelties in Gastrointestinal Surgery (Deadline: 30 May 2024)
- Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Management: 2nd Edition (Deadline: 31 May 2024)
- Recent Advances and Future Challenges in Hepatobiliary Surgery (Deadline: 31 May 2024)
- Genomics and Proteomics in Gastrointestinal Disorders (Deadline: 30 June 2024)
- Ulcerative Colitis: Diagnosis and Management (Deadline: 30 June 2024)
- Diagnostic Procedures and Treatment for Biliary Diseases (Deadline: 21 July 2024)
- Robotic Colorectal Oncological Surgery: New Insights and Perspectives (Deadline: 31 July 2024)
- New Trends in Crohn’s Disease and Ulcerative Colitis (Deadline: 20 August 2024)
- Latest Advances in Pancreatobiliary Endoscopy (Deadline: 31 August 2024)
- Advance in the Diagnosis, Treatment and Prognosis of Hepatocellular Carcinoma (Deadline: 31 August 2024)
- Gallbladder, Bile Duct and Pancreas Disorders: Current Challenges, New Perspectives and Innovative Techniques (Deadline: 30 September 2024)
- Novelties in Chronic Liver Diseases (Deadline: 30 September 2024)
- Advances in Cholecystitis and Cholecystectomy (Deadline: 20 November 2024)
- Recent Advances and Future Challenges in Colorectal Surgery (Deadline: 30 November 2024)
- Editorial Board Members’ Collection Series: Gastrointestinal and Hepatic Diseases (Deadline: 31 December 2024)